Trade Precision BioSciences, Inc. - DTIL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0916 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02354% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001318% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.5042 |
| Open | 4.6742 |
| 1-Year Change | -63.85% |
| Day's Range | 4.4842 - 4.6742 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | 4.6342 | -0.0900 | -1.91% | 4.7242 | 4.7242 | 4.4842 |
| Mar 27, 2025 | 4.5042 | -0.2700 | -5.66% | 4.7742 | 4.7742 | 4.4642 |
| Mar 26, 2025 | 4.4942 | -0.4700 | -9.47% | 4.9642 | 4.9742 | 4.2842 |
| Mar 25, 2025 | 5.1242 | -0.3200 | -5.88% | 5.4442 | 5.4442 | 5.1042 |
| Mar 24, 2025 | 5.5742 | 0.1400 | 2.58% | 5.4342 | 5.6742 | 5.4342 |
| Mar 21, 2025 | 5.3742 | 0.0000 | 0.00% | 5.3742 | 5.4142 | 5.0742 |
| Mar 20, 2025 | 5.2642 | 0.2600 | 5.20% | 5.0042 | 5.3242 | 4.9242 |
| Mar 19, 2025 | 4.9142 | 0.0300 | 0.61% | 4.8842 | 4.9442 | 4.7942 |
| Mar 18, 2025 | 4.9442 | 0.0200 | 0.41% | 4.9242 | 4.9742 | 4.7842 |
| Mar 17, 2025 | 5.0042 | -0.3700 | -6.88% | 5.3742 | 5.3942 | 4.9042 |
| Mar 14, 2025 | 4.9542 | -0.0700 | -1.39% | 5.0242 | 5.1242 | 4.8942 |
| Mar 13, 2025 | 5.0242 | -0.0600 | -1.18% | 5.0842 | 5.1142 | 4.9642 |
| Mar 12, 2025 | 4.9942 | 0.1200 | 2.46% | 4.8742 | 5.0842 | 4.8542 |
| Mar 11, 2025 | 4.9842 | -0.0900 | -1.77% | 5.0742 | 5.0742 | 4.8742 |
| Mar 10, 2025 | 5.0742 | -0.0200 | -0.39% | 5.0942 | 5.1442 | 4.9742 |
| Mar 7, 2025 | 5.1042 | 0.1100 | 2.20% | 4.9942 | 5.1942 | 4.9742 |
| Mar 6, 2025 | 5.1142 | 0.0700 | 1.39% | 5.0442 | 5.2642 | 4.9742 |
| Mar 5, 2025 | 5.1842 | 0.1100 | 2.17% | 5.0742 | 5.2242 | 4.9742 |
| Mar 4, 2025 | 4.9742 | 0.0000 | 0.00% | 4.9742 | 4.9742 | 4.6542 |
| Mar 3, 2025 | 4.9742 | -0.1500 | -2.93% | 5.1242 | 5.2342 | 4.9742 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Precision BioSciences, Inc. Company profile
About Precision BioSciences Inc
Precision BioSciences, Inc is a clinical stage biotechnology company. The Company’s ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make specific cuts and DNA insertions in cellular DNA. The Company’s pipeline includes Ex vivo Allogeneic CAR T Immunotherapy and In vivo Gene Correction. Its Ex vivo Allogeneic CAR T Immunotherapy pipeline offers programs, including PBCAR0191, PBCAR19B, PBCAR269A and CD19 Combination with Foralumab. Its in-vivo Gene Correction pipeline offers three preclinical programs, including PBGENE-PCSK9, PBGENE-PH1 and PBGENE-HBV. The Company’s subsidiaries include Precision PlantSciences, Inc. and Precision BioSciences UK Limited.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Precision BioSciences Inc revenues increased from $24.3M to $115.5M. Net loss decreased 72% to $30.6M. Revenues reflect Therapeutics segment increase from $21.9M to $111.7M, Food segment increase of 57% to $3.8M. Lower net loss reflects Therapeutics segment income totaling $32M vs. loss of $50M, Food segment loss decrease of 26% to $3.8M.
| Industry: | Biotechnology & Medical Research (NEC) |
302 E Pettigrew St Ste A100
DURHAM
NORTH CAROLINA 27701-2393
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com